XOMA (XOMA) – Business Wire
-
LadRx Issues 2024 Update to Shareholders
-
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
-
AmMax Bio Announces the Appointment of Biotechnology Executive, John Varian, as Independent Board Member
-
Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors
Back to XOMA Stock Lookup